Current practice of ototoxicity management across the United Kingdom (UK)

Abstract

Objective: Effective management of patients diagnosed with ototoxicity is needed to reduce hearing and balance damage which affects communication and life quality. Despite widespread recommendations to monitor and manage ototoxicity in an early and effective manner, there is limited evidence to support the actual implementation of these recommendations for affected patient groups in healthcare services across the UK with limited publications available. In this study, an online questionnaire analysed the current practice of ototoxicity management and patient pathways across the UK once the diagnosis of ototoxicity was confirmed, targeting Audiologists, ENTs/AVPs and GPs. Design: Qualitative Survey Study. Study sample: A randomised sample of hearing services in the UK, including audiology departments; GP practices and local health settings were targeted with a total of 134 completed surveys. Results: About 72% reported the absence of ototoxicity management protocols within their centre. Results depicted great inconsistency and variation across the UK in ototoxicity management services provided, treatment modification, monitoring and referral pathways. Conclusion: Developing and advocating national guidelines are intended not only to inform clinical decision making but to provide minimum standards of care in ototoxicity management and offer greater awareness and education to improve patients’ quality of life.

Key Words:

• Ototoxic agents
• ototoxicity management
• audiologists
• ENTS/AVPs
• GPs
• aminoglycoside ototoxicity
• cisplatin ototoxicity
• ototoxicity monitoring
• paediatric ototoxicity management
• balance management
• ototoxicity education

Acknowledgements

The authors express their sincere gratitude to Mr Chris Cartwright, Audiology Development Manager for Phonak, for assisting in distributing the survey. They are also extremely grateful to all the respondents who spent the time to complete our questionnaire.

Declaration of interest: No potential conflict of interest was reported by the author(s).